Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi: 10.1038/nprot.2006.378
Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
These drugs also exhibit additional benefits, such as cardio- and neuroprotection, anti-inflammatory properties, and modulation of reward and food intake behaviors
Consistent with this notion, we observed an upregulation of the required enzymatic machinery for local processing of GLP-1 including Glp1r, Pcsk1 and Dpp4 mRNAs in the OB of obese mice compared to lean mice
US$ 20.57
US$ 24.26
US$ 29.71
/assets/images/provider/photos/2775905.jpeg)
